Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy Post author:Sam Post published:February 7, 2018 Post category:BioPharma The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy. Source: BioSpace You Might Also Like Pfizer Unveils ATLAS, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries April 20, 2017 Boston's Anti-Aging Startup resTORbio Scores $40M November 29, 2017 Patient Dies in Cellectis' Groundbreaking CAR-T Trial, Forcing a Halt to Trials September 4, 2017
Pfizer Unveils ATLAS, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries April 20, 2017
